Endothelial dysfunction in diabetes mellitus

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 5, 2000, Pages 503-511

  Schiekofer, S ^a   Balletshofer, B ^a   Andrassy, M ^a   Bierhaus, A ^a   Nawroth, P P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cardiovascular disease; Diabetes; Endothelium; Hyperglycemia; Vascular permeability

Indexed keywords

BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HUMAN; HYPERGLYCEMIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0033635834     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13206     Document Type: Review

References (99)

1. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo preventive trial with diet and exercise
2. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects
3. Prevention of type II diabetes in subjects with impaired glucose tolerance: The diabetes prevention study (DPS) in Finland
4. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose
5. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals
6. Hyperglycemia and cardiovascular disease in type 2 diabetes
7. Diabetic peripheral neuropathy: Effects of age duration of diabetes, glycemic control, and vascular factors
8. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): A cohort study
9. Review of diabetes: Identification of markers for early detection, glycemic control, and monitoring clinical complications
10. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients
11. The tumor necrosis factor alpha-238 G → A and -308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type II diabetic patients
12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial
14. Diabetes and decline in heart disease mortality in US adults
15. Sex-based differences in early mortality after myocardial infarction
16. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
17. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
18. Vascular reactivity
19. Endothelial dysfunction: Update and clinical implications
20. Endothelium and regulation of coagulation
21. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men
22. Vascular dysfunction in diabetes mellitus
23. Early endothelial alterations in non-insulin-dependent diabetes mellitus
24. Endothelial dysfunction and pathogenesis of diabetic angiopathy
25. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose
26. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells
27. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
28. Elevated plasma endothelin in patients with diabetes mellitus
29. Endothelin: Emerging role in diabetic vascular complications
30. Upregulation of endothelin at receptor sites in the rabbit diabetic kidney: Potential relevance to the early pathogenesis of diabetic nephropathy
31. Role of endothelin-1 in diabetes mellitus
32. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries
33. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina
34. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes
35. Endothelin is a key modulator of progressive renal injury: Experimental data and novel therapeutic strategies
36. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy
37. Endothelins in the normal and diseased kidney
38. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
39. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
40. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
41. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
42. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modifications
43. Pathogenic effects of advanced glycosylation: Biochemical, biological and clinical implications for diabetes and aging
44. Products of advanced glycosylation and the pathogenesis of accelerated atherosclerosis in diabetes
45. Oxidative stress and diabetic vascular complications
46. Diabetes mellitus, hypertension and cardiovascular disease: Which role for oxidative stress?
47. Oxidants downstream from superoxide inhibit nitric oxide production by vascular endothelium: A key role for selenium-dependent enzymes in vascular health
48. Hemodynamic shear stress and its role in atherosclerosis
49. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
50. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
51. Noninvasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
52. Endothelial dysfunction is detectable in young normotensive first degree relatives of subjects with type 2 diabetes in association to insulin resistance
53. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects
54. The cellular and molecular mechanisms of diabetic complications
55. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia
56. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
57. The role of oxygen radicals in human disease, with particular reference to the vascular system
58. Angiotensin II and oxidized LDL: An unholy alliance creating oxidative stress
59. Effect of angiotensin II on vascular remodeling
60. Angiotensin II stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells
61. Effect of ACE inhibition on neurohormones
62. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: A randomized, double-blind study
63. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus
64. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis
65. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro
66. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells
67. Atherosclerosis involves more than just lipids: Focus on inflammation
68. Atherosclerosis involves more than just lipids: Plaque dynamics
69. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia
70. Endothelial dysfunction in diabetes mellitus
71. Nitrate induced coronary vasodilatation: Differential effects of sublingual application by capsule or spray
72. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes
73. Suppression of N-epsilon-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine
74. The physiology and pathophysiology of the nitric oxide/superoxide system
75. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type I isoform
76. Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes
77. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rat
78. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C
79. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment
80. Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration
81. Endothelium dysfunction in the coronary circulation
82. Heparin/heparan sulfate chelation inhibits control of vascular repair by tissue-engineered endothelial cells
83. Pentosan polysulfate decreases proliferation and net extracellular matrix production in mouse mesangial cells
84. Prevention of microvascular complications in diabetic children and adolescents
85. Preventing end-stage renal disease
86. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
87. N-epsilon-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
88. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus
89. Von Willebrand factor in diabetic angiopathy
90. Effects of gamma linolenic acid supplementation on rheological properties of erythrocytes in type 2 diabetic patients with peripheral polyneuropathy
91. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes
92. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
93. Should high-dose vitamin E supplementation be recommended to diabetic patients?
94. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults
95. A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette
96. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction
97. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients
98. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging